
Accelerated Production Process
Streamlined workflows to ensure efficient scale-up and reduce time-to-market.

Delivering comprehensive solutions to meet the unique demands of the pharmaceutical industry. From enabling R&D for life-saving discoveries to optimizing drug formulations, Scimplify is a trusted leader among intermediate and active pharma ingredient manufacturers.
Global pharmaceutical landscape is experiencing a structural shift toward supply chain resilience. Modern innovators are rapidly transitioning away from fragmented, volatile merchant brokers toward deeply integrated development models that mitigate geopolitical instability, sudden regulatory actions, and core material shortages. Operating across 25+ consumer countries, including the United Kingdom, Japan, Italy, Spain, and South Korea — Scimplify connects this market gap. We act as an end-to-end partner by running a manufacturing network composed of 75+ GMP-audited facilities and 3 in-house R&D centres. This scale ensures our global life sciences partners benefit from diversified, backward-integrated supply chains that protect downstream commercial interests from any market disruption and coordinate the ever-evolving pharmaceutical advances.

Streamlined workflows to ensure efficient scale-up and reduce time-to-market.

Delivering high-quality manufacturing solutions to ensure your product is ready for commercial success.

Supporting all stages of manufacturing, from initial pilot production to full-scale commercial production.
100% guarantee on the quality of chemicals with a robust 3-step quality inspection process
Capabilities for producing APIs and Intermediates in controlled quantities tailored to your needs.
Cutting-edge research and development to improve process efficiency during manufacturing
Built on science, quality and trust
75+ GMP sites
Multi-nuclear NMR & HPCL
Regulatory ready Dossiers
Scimplify's platform utilises an advanced, asset-light manufacturing aggregation model. By combining internal process optimisation specialists with thoroughly vetted, Tier-1 contract manufacturing sites, we eliminate the capacity constraints typical of standalone legacy providers. For commercial procurement teams and technical directors, this structure delivers cost efficiency alongside rapid operational scaling.
APIs, Intermediates, Pellets, Formulations, Key Starting Materials & Excipients
R&D, CDMO, Generics and NCEs
CDMO & Regulatory Support
Full-Spectrum Pharma Manufacturing & Sourcing
Trusted API Exporter India, delivering high-quality Ferric Carboxymaltose and pharmaceutical APIs to 10+ countries
Scimplify's network runs complex organic reactions safely across a broad range of temperatures and pressures - from milligrams in the lab to hundreds of tonnes a month on the plant floor.
MTM COMBINED INSTALLED CAPACITY
Scientists
In-house R&D labs
PhDs
Core chemistries
Patents
Molecules developed (Japan, USA, Taiwan, China, India)
Molecules evaluated in CDMO
A curated selection of our APIs, intermediates, and pellets manufactured across regulated and emerging markets.
Active Pharmaceutical Ingredients (APIs) Master Portfolio
| Product Name | Pharmacopeia Status | Therapeutic Category |
|---|---|---|
| Folic Acid | IP / USP | Vitamin B9 / Nutraceutical |
| Itraconazole | IP / USP / BP | Anti-Fungal Active |
| Rabeprazole Sodium | IP / USP | Gastrointestinal / GERD Care |
| Omeprazole | IP / USP | Gastrointestinal / GERD Care |
| Apremilast | USP | Anti-Inflammatory / PDE4 Inhibitor |
| Clopidogrel Bisulfate | IP / USP | Anti-Platelet / Cardiovascular |
| Orlistat | IH / USP | Anti-Obesity / Lipase Inhibitor |
| Tacrolimus | IP / USP / BP / EP | Immunosuppressant |
| Aceclofenac | IP / USP | NSAID / Pain Management |
| Valsartan | IP / USP / BP | Anti-Hypertensive / Cardiovascular |
| Losartan Potassium | IP / USP / BP | Anti-Hypertensive / Cardiovascular |
| Faropenem | JP | Penem Antibiotic / Anti-Infective |
| Deflazacort | IH | Corticosteroid / Anti-Inflammatory |
| Hydrocortisone Acetate | IP / USP | Corticosteroid / Anti-Inflammatory |
| Clobetasone Propionate | IP / USP / BP / Ph.Eur | Topical Corticosteroid / Dermatology |
| Levosulpiride | IP | Antipsychotic / Prokinetic |
| Montelukast | IP / USP | Anti-Asthmatic / Leukotriene Antagonist |
From our hub in India, Scimplify connects a live network of manufacturing, sourcing, and regulatory partners spanning every major pharmaceutical market worldwide.

APIs, Intermediates, Excipients & KSMs, Pellets & Formulations under one roof

Lab to commercial execution with QC & documentation

Regulatory-ready dossiers & global compliance support

75+ GMP-audited sites for flexible manufacturing

Cross-border sourcing, logistics & regulatory support

Licensing, co-development & strategic supply partnerships
From lab-scale testing to pilot-scale production to finished formulations and regulatory support, our CRO services are designed to streamline your journey to market with precision and expertise.
From lab-scale testing to pilot-scale production to finished formulations and regulatory support, our CRO services are designed to streamline your journey to market with precision and expertise.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Isopropoxyaniline (CAS No: 41406-00-2), commercially referred to as 3-IPA or m-isopropoxyaniline, ...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 2,6-Difluorobenzamide (CAS No: 18063-03-1) is undergoing a significant transition from a niche aroma...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Fluorophenol (CAS No: 372-20-3), also known as m-fluorophenol, is undergoing a significant transit...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Hydroxybenzotrifluoride (CAS No: 98-17-9), also known as mHBTF, is undergoing a significant transi...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Faropenem sodium (CAS 106560-14-9) is experiencing a strategic resurgence in the global anti-infecti...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Tacrolimus (CAS No: 104987-11-3) continues to serve as a cornerstone calcineurin inhibitor within th...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : The global orlistat market is experiencing a significant shift as pharmaceutical manufacturers incre...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Apremilast (CAS No: 608141-41-9) represents a pivotal advancement in the global speciality chemicals...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Bromo-8-methylimidazo[1,2-a]pyridine-6-carboxylic acid (C₉H₇BrN₂O₂) is a highly functionalised, bi...
Category : Excipients
Sub-Category : Solvents & Solubilizers
Description : Our N,N-Dimethylacetamide (DMAc) is a premium, high-purity polar aprotic industrial solvent engineer...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : tert-Butyldimethylsilane (CAS No: 29681-57-0) serves as a critical silicon-based reagent in the high...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : Piperazine (CAS No: 110-85-0) is a versatile heterocyclic building block highly valued in the global...
Ensure globally resilient supply chains
Backed by 10+ patents and decades of experience.
Tailored support for your unique needs.
Delivering to 30+ countries.
2788 products available across our life science range.
Enter your personal data to create your account